New COVID-19 Vaccination Guidelines for Immunocompromised Individuals

The Infectious Diseases Society of America (IDSA) issued a “strong recommendation” for COVID-19 vaccination in immunocompromised individuals based on a “moderate certainty of evidence” in new guidelines. The IDSA panel conducted a literature review of 14 COVID-19 vaccine effectiveness studies published since June 2024, which primarily examined messenger RNA vaccination, in immunocompromised populations.